COMBINATION THERAPY WITH A PROTEASOME INHIBITOR AND A GALLIUM COMPLEX

摘要

A combination therapy is disclosed for treating cancer. The method comprises identifying a patient diagnosed of cancer and in need of treatment, administering to a cancer patient a therapeutically effective amount of a compound of Formula (I), and administering to said patient a therapeutically effective amount of a proteasome inhibitor.